Compare ITSEC Asia Tbk. (CYBR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ITSEC Asia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? ITSEC Asia Tbk. trades at Rp595 (market cap 7.95T, 26.72M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: ITSEC Asia Tbk. is far larger — about 13.6× UBC Medical Indonesia Tbk.'s market cap, and ITSEC Asia Tbk. is more actively traded (26.72M versus 817.3K). Which is the better fit depends on your goals.
| CYBR | LABS | |
|---|---|---|
Market Cap | 7.95T | 584.6B |
Volume | 26.72M | 817.3K |
Lot | 267.25K | 8.17K |
Turnover | 15.89B | 120.01M |
Average Price | 594.54 | 146.84 |
Value | 15.89B | 120.01M |
Indicative Equilibrium Price | 595 | 146 |
Indicative Equilibrium Volume | 204 | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ITSEC Asia Tbk.
PT ITSEC Asia Tbk (the “Company”) was established based on Notarial Deed No. 7 dated April 12, 2010 of Refizal, S.H., M.Hum., notary in Jakarta. The Company started its commercial operations in 2010.
Read more on CYBR →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
